
Opinions
Cameron Hurst
Teva PharmaceuticalTEVASELLAug 09, 2017
$17.50
Stock price when the opinion was issued
$31.48
As of Jun 18, 2026. Market Open.
biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
It was their guidance that hit them as well as an earnings miss. There were a number of factors that came up. Technically, it has broken badly, and fundamentally there are major question marks. If you own, take your capital and invest it somewhere that has more near term brighter prospects.